Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.
Nakazawa N, Sohda M, Tateno K, Watanabe T, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kogure n. In Vivo. 2023 Mar-Apr;37(2):818-824. doi: 10.21873/invivo.13147. In Vivo. 2023. PMID: 36881071 Free PMC article.
Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study.
Nakazawa N, Sohda M, Tateno K, Watanabe T, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kogure n. Anticancer Res. 2023 Feb;43(2):927-934. doi: 10.21873/anticanres.16236. Anticancer Res. 2023. PMID: 36697068
Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study.
Nakazawa N, Sohda M, Ubukata Y, Kuriyama K, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kogure n. Ann Surg Oncol. 2022 Nov;29(12):7400-7406. doi: 10.1245/s10434-022-12226-4. Epub 2022 Jul 20. Ann Surg Oncol. 2022. PMID: 35857197 Review.
Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: a multicenter retrospective study.
Sano A, Sohda M, Nakazawa N, Ubukata Y, Kuriyama K, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sakai M, Ogawa H, Shirabe K, Saeki H. Sano A, et al. Among authors: kogure n. BMC Cancer. 2022 Jan 3;22(1):22. doi: 10.1186/s12885-021-09118-3. BMC Cancer. 2022. PMID: 34980017 Free PMC article.
Thyroid hormone activated upper gastrointestinal motility without mediating gastrointestinal hormones in conscious dogs.
Nakazawa N, Sohda M, Ogata K, Baatar S, Ubukata Y, Kuriyama K, Hara K, Suzuki M, Yanoma T, Kimura A, Kogure N, Sano A, Sakai M, Yokobori T, Oue A, Mochiki E, Kuwano H, Shirabe K, Koibuchi N, Saeki H. Nakazawa N, et al. Among authors: kogure n. Sci Rep. 2021 May 11;11(1):9975. doi: 10.1038/s41598-021-89378-y. Sci Rep. 2021. PMID: 33976260 Free PMC article.
90 results